Navigation Links
Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008
Date:10/28/2008

Smartlipo MPX Workstation and International Business Drive Top-Line Growth;

Company Posts Eighth Consecutive Quarter of Profitability

WESTFORD, Mass., Oct. 28 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced financial results for the three and nine months ended September 30, 2008.

Third-Quarter 2008 Financial Results

Revenues increased to $38.2 million for the third quarter of 2008 from $31.5 million for the third quarter of 2007. Gross profit margin was 64.9% of total revenues, compared with 65.0% for the same period in 2007. Net income for the third quarter of 2008 was $3.2 million, or $0.25 per diluted share, compared with net income of $4.4 million, or $0.34 per diluted share, for the third quarter of 2007. Results for the third quarter of 2008 include a foreign currency exchange loss of $0.4 million, compared with a foreign currency exchange gain of $0.5 million in the third quarter of 2007.

Non-GAAP net income, which excludes stock-based compensation expense and its related income tax effects, was $4.7 million, or $0.37 per diluted share, for the third quarter of 2008, compared with non-GAAP net income of $5.1 million, or $0.40 per diluted share, for the third quarter of 2007. Please refer to the financial reconciliations included in this news release for a reconciliation of GAAP results to non-GAAP results for the three months ended September 30, 2008 and 2007.

"Cynosure posted strong third-quarter results despite challenging global economic conditions, generating revenue growth of more than 20% over the prior year period and delivering our eighth consecutive quarter of
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Cynosure to Present at the Maxim Group Growth Conference
2. Cynosure to Announce Third-Quarter 2007 Financial Results on November 1
3. Cynosure Files Patent Infringement Lawsuit Against CoolTouch Inc.
4. CoolTouch Inc. Responds to Cynosure Patent Infringement Lawsuit
5. Cynosure Launches Three Aesthetic Products at American Academy of Dermatology 2008 Annual Meeting
6. Cynosure to Announce First-Quarter 2008 Financial Results on April 29
7. Cynosures Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval
8. Cynosure to Present at 2008 Citi Investment Research Global Health Care Conference
9. Cynosure Expands Presence in China with the Opening of Sales Office in Beijing
10. Cynosure President and CEO Michael Davin Named Ernst & Young Entrepreneur of the Year(R) 2008 Award Winner in New England
11. Cynosure to Announce Second-Quarter 2008 Financial Results on July 29
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Spring and summer have always been motivation for people ... the city between Memphis and Nashville? In the last year ... has transformed the growing area into one of the most ... of vibrant, young professionals you are going to see demand ... owner of The Fight Shop, one of the city’s hottest ...
(Date:5/23/2013)... Jeanne Ettelson, president of Beyond ... and only free OCD support group in Chicago. ... OCD sufferers, the group is lead by psychologists who ... This allows group participants to learn accurate information about ... , “Participants in Beyond OCD’s support group benefit ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 EnvirOasis, ... the contractor and ESCO market is pleased to announce ... Consortium (DLC) Listed LED products. EnvirOasis has been ... fixtures and retrofit kits and has recently brought ... LED (Light Emitting Diode) is energy efficient lighting ...
(Date:5/23/2013)... Symptoms of borderline personality disorder often mimic traits ... But researchers in Canada say they have identified ... personality disorder: a tendency to misinterpret emotions expressed ... processing facial emotions and will see a negative ... a clinical neuropsychologist and assistant professor at the ...
(Date:5/23/2013)... A shortage of a critical tuberculosis drug has hampered ... to contain the spread of the highly infectious lung ... was first used in 1951 and is one of ... first-line treatment for tuberculosis (TB). Patients must take the ... U.S. Centers for Disease Control and Prevention. However, ...
Breaking Medicine News(10 mins):Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 3Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 4Health News:Beyond OCD Support Group Marks Fifth Anniversary 2Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3Health News:Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report 2
... asks board member to seek restatement of Beth ... Massbank director Allan,Bufferd should apply the same ... companies to his role on the board of ... group 1199 SEIU United,Healthcare Workers East. Bufferd is ...
... Bulletin Board: GXYF), a leading developer and marketer of,cheese ... today announced that it will host an investor conference ... the 2008 fiscal year at,11:00 a.m. EST on Friday, ... results before the market opens the same day., ...
... board member to seek restatement of Beth Israel Deaconess,Medical ... CEO and,director Robert Lepofsky should apply the same Sarbanes-Oxley ... his role as Vice,Chairperson of the board of CareGroup, ... according to labor group 1199 SEIU,United Healthcare Workers East., ...
... Sodium and salt levels in foods and,beverages are on ... food,and beverage industry. Why? In two words -- health concerns. ... or No Sodium or Salt,Foods and Beverages in the U.S., ... foodservice menu items and beverages. All of,which have been argued ...
... is also available in German . , ... are childless against their will. The microscopic procedure significantly improves ... was discovered by scientists at the University of Bonn together ... of 124 women. Up to now, the desire to have ...
... markets strong, ADA, Mich., Feb. 6 Alticor ... $7.1 billion for the year ended Dec. 31,2007, a ... Company officials attributed the increase to continued growth ... America, a rebound in,China following the long-awaited establishment of ...
Cached Medicine News:Health News:Massbank Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:Galaxy Nutritional Foods Announces Third Quarter FY2008 Earnings Conference Call for Friday, February 8, 2008 2Health News:Brooks Automation Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns 2Health News:Significantly higher success rates with artificial insemination 2Health News:Alticor's 2007 Global Sales Top $7 Billion 2Health News:Alticor's 2007 Global Sales Top $7 Billion 3Health News:Alticor's 2007 Global Sales Top $7 Billion 4Health News:Alticor's 2007 Global Sales Top $7 Billion 5Health News:Alticor's 2007 Global Sales Top $7 Billion 6
(Date:5/23/2013)... 2013  Echo Pharma Acquisition Limited ("Royalty Pharma") announced ... Acceptance Threshold from 90 percent to 50 percent of ... accordance with the terms of the Revised Offer Document ... Under the terms of the Increased Offer, Royalty ... ELN ) for $12.50 per share in cash. The ...
(Date:5/23/2013)... 2013   BioLife Solutions , Inc. (OTC:BLFS), a ... hypothermic storage and cryopreservation freeze ... media manufacturer , today announced its participation at the ... 2013 this week in London ... Dr. Aby J. Mathew, BioLife,s Senior Vice President and ...
(Date:5/23/2013)... PARIS , May 23, 2013  Volcano ... and manufacturer of precision guided therapy tools designed to ... vascular disease, today announced preliminary results from the ADVISE ... S tenosis E valuation) II trial during ... EuroPCR 2013. These prospective results confirm prior retrospective publications, ...
Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5
... N.J., Aug. 31 QRxPharma (ASX: QRX and OTCQX: ... the 13th World Congress of Pain on 31 August, ... titled "Dual Opioid Therapy: Changing the Paradigm" will focus ... Dual Opioid product for moderate to severe acute pain. ...
... PHILADELPHIA, Aug. 31 Shire plc (LSE: ... biopharmaceutical company, today announced its support for inflammatory bowel ... country.  The six fellowships will begin in 2011 and ... of IBD to physicians who recently completed a fellowship ...
Cached Medicine Technology:QRxPharma to Sponsor Symposium at 13th World Congress on Pain Meeting 2QRxPharma to Sponsor Symposium at 13th World Congress on Pain Meeting 3Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships at Leading Medical Institutions Nationwide 2Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships at Leading Medical Institutions Nationwide 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: